COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

https://created.crayola.com/network/members/profile?UserKey=bd1dc827-3464-4602-966b-5fdf2a5755f4
https://created.crayola.com/network/members/profile?UserKey=adfad3b2-2541-4a9e-8794-c726b1803c84
https://created.crayola.com/network/members/profile?UserKey=0f7aeda3-feed-49ec-95b8-8e4c692aa7c9
https://created.crayola.com/network/members/profile?UserKey=157ad0a9-2906-493c-bc4d-249b62064a67
https://created.crayola.com/network/members/profile?UserKey=b3ff088b-9027-4bf0-8c0d-4771275c15b8
https://created.crayola.com/network/members/profile?UserKey=9b365f2d-3ec5-48b8-bd5a-08ee9e483e72
https://created.crayola.com/network/members/profile?UserKey=10aa9682-2725-405d-9608-1a94afb4e6aa
https://created.crayola.com/network/members/profile?UserKey=fe99026a-cac0-4b15-b8bc-6b34c1373c21
https://created.crayola.com/network/members/profile?UserKey=9008ea24-a7e4-444e-87c0-6957a3b765ba
https://created.crayola.com/network/members/profile?UserKey=76920609-ed83-4903-bae0-05c495acb50f
https://created.crayola.com/network/members/profile?UserKey=d78874b9-f0c5-4817-a554-784075f62440
https://created.crayola.com/network/members/profile?UserKey=35d1e67b-063a-49b2-a411-ed2fc375badc
https://created.crayola.com/network/members/profile?UserKey=7543d086-6d43-4718-87d8-b90098f8c9d8
https://created.crayola.com/network/members/profile?UserKey=70dc1901-13a8-4b96-b235-e41b111c7cb5
https://created.crayola.com/network/members/profile?UserKey=b7ff6923-f523-4f6a-a580-4622d1422af8
https://created.crayola.com/network/members/profile?UserKey=1245601a-74ec-445a-a191-acd2c7e92a34
https://created.crayola.com/network/members/profile?UserKey=1f4afe7b-57cd-4b11-acef-c647d0ec00d5
https://created.crayola.com/network/members/profile?UserKey=d949297e-a672-4739-81a6-397bd4a17029
https://created.crayola.com/network/members/profile?UserKey=034ce934-1929-484a-b382-255bf8ed89d8
https://created.crayola.com/network/members/profile?UserKey=38fc4ada-5c26-4332-a735-bd6f0a674bfa
https://jsfiddle.net/fakultasekonomi/a2hef4b5/
https://onlinegdb.com/S-skPdepg
https://ideone.com/Ocbf2D
https://paiza.io/projects/YLc0xx8IBgv7HrMwBOar1Q
http://cpp.sh/6xomr
https://minimore.com/b/6Oo3j#
https://radonlife.com/inventory/full-time/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or-lengthier-hospital-stays.html
https://www.mydigoo.com/forums-topicdetail-276720.html
https://dcm.shivtr.com/forum_threads/3438775
https://cox.tribe.so/post/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or---60aa979cf417944e3c806a8d
https://cox.tribe.so/post/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or---60aa97cb7d20484a334b2818
https://cox.tribe.so/question/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or---60aa97b0f41794c8ec806a90
https://www.peeranswer.com/question/60aa958151322b513458b1c1
https://myanimelist.net/blog.php?eid=859549
https://dumpz.org/aPmcnSDQZSqF
http://paste.jp/85a5dcb1/
https://rentry.co/36bt3
https://gumroad.com/movieonlinefree/p/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or-lengthier-hospital-stays
https://medium.com/@bsnigdhoprohor2c/covid-19-patients-with-liver-injuries-are-at-a-higher-risk-of-mortality-or-lengthier-hospital-stays-53786479648d
https://afatirajawi3.substack.com/p/covid-19-patients-with-liver-injuries
https://afatirajawi3.substack.com/p/covid-19-patients-with-liver-injuries-faa/comments
https://www.linkedin.com/pulse/covid-19-patients-liver-injuries-higher-risk-hospital-fata-alhusna
https://www.linkedin.com/posts/fata-alhusna-8194481b9_httpslnkdinghtfpq-activity-6802294499830833152-D2W7

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space

Play Video
New research presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting shows that liver injuries are common in hospitalized COVID-19 patients.

A team, led by Joshua Bender, Columbia University Vagelos College of Physicians and Surgeons, found these injuries are associated with an increased risk of lengthy intensive care unit stays or death.

In the retrospective cohort study, the researchers examined data from 551 hospitalized COVID-19 patients at New York-Presbyterian Hospital/Columbia University Irving Medical Center between March 1 and May 31, 2020.

The investigators analyzed patient demographics, laboratory test results, vital signs, medical history, and clinical outcomes for this patient population and characterized liver injuries for patients with abnormal alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) activities as cholestatic, mixed, or hepatocellular.

Overall, 58.2% of patients had a cholestatic injury pattern, 35.2% were mixed, and 6.6% of the patient population hepatocellular injury.

In addition, any comorbid liver disease, cirrhosis, or hepatitis C was not associated with clinical outcome, while abnormal direct bilirubin and albumin on admission was linked to length of ICU stay and mortality.

In an interview with HCPLive®, Bender analyzed what the study results mean and how the COVID-19 pandemic has impacted medical care and research in virtually every space